A hemoperfusion column selectively adsorbs LAP+ lymphocytes to improve anti-tumor immunity and survival of tumor-bearing rats. Teramoto K, Ueda Y, Murai R, Ogasawara K, et al. PLoS One 2025;20:e0305153.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Teramoto K, Ueda Y, Murai R, Ogasawara K, et al. A hemoperfusion column selectively adsorbs LAP+ lymphocytes to improve anti-tumor immunity and survival of tumor-bearing rats. PLoS One 2025;20:e0305153.
PMID: 40053558